Page last updated: 2024-09-03

gefitinib and Pregnancy, Tubal

gefitinib has been researched along with Pregnancy, Tubal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhattacharya, S; Bottomley, C; Bourne, T; Coomarasamy, A; Daniels, J; Doust, A; Duncan, C; Hewitt, C; Horne, AW; Jurkovic, D; May, J; Middleton, L; Mol, B; Peace-Gadsby, A; Tong, S	1

Trials

1 trial(s) available for gefitinib and Pregnancy, Tubal

Article	Year
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol. Trials, 2018, Nov-20, Volume: 19, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Adolescent; Adult; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Therapy, Combination; ErbB Receptors; Female; Gefitinib; Humans; Methotrexate; Middle Aged; Multicenter Studies as Topic; Pregnancy; Pregnancy, Tubal; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; United Kingdom; Young Adult	2018

Article

Year

A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol.

Trials, 2018, Nov-20, Volume: 19, Issue:1

Topics: Abortifacient Agents, Nonsteroidal; Adolescent; Adult; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Therapy, Combination; ErbB Receptors; Female; Gefitinib; Humans; Methotrexate; Middle Aged; Multicenter Studies as Topic; Pregnancy; Pregnancy, Tubal; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; United Kingdom; Young Adult

2018